Using detection of >20% CLL-like cells in the blood as a threshold for leukemia onset, Eμ-MTCP1 founder lines Z36 and Z20 reached “diseased” status at a median time of 7.7 and 16.7 months, respectively (Fig. 2C). Here, MTCP1 is linked to B-cell chronic lymphocytic leukemia.